Systemic innate immune responses following intrapulmonary delivery of CpG oligodeoxynucleotides in sheep

Veterinary Immunology and Immunopathology

Volumn 115, Issue 3-4, 2007, Pages 357-368

  Nichani, Anil K ^a   Dar, M Arshud ^a   Krieg, Arthur M ^b   Mirakhur, Kuldip K ^a   Kaushik, Radhey S ^a   Griebel, Philip J ^a   Manuja, Anju ^a   Townsend, Hugh G G ^a   Babiuk, Lorne A ^a   Mutwiri, George K ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b PFIZER INC   (United States)

Author keywords

2 5 A synthetase; CpG oligodeoxynucleotides; Formulation; Interferons; Intrapulmonary delivery; Sheep

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; CPG 2006; CPG 2006GC; CPG 2007; CPG 2429; CPG OLIGODEOXYNUCLEOTIDE; EMULSIGEN; HAPTOGLOBIN; IMMUNOSTIMULATING AGENT; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG INFUSION; FEMALE; INNATE IMMUNITY; MALE; MUCOSAL IMMUNITY; NONHUMAN; PROTEIN BLOOD LEVEL; RECTUM TEMPERATURE; SHEEP;

2',5'-OLIGOADENYLATE SYNTHETASE; ADJUVANTS, IMMUNOLOGIC; ANIMALS; BODY TEMPERATURE; HAPTOGLOBINS; IMMUNITY, NATURAL; MALE; OLIGODEOXYRIBONUCLEOTIDES; RESPIRATORY MUCOSA; SHEEP;

ANIMALIA; MUS; OVIS ARIES;

EID: 33846222461     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2006.11.013     Document Type: Article

References (47)

1. Abel K., Wang Y., Fritts L., Sanchez E., Chung E., Fitzgerald-Bocarsly P., Krieg A.M., and Miller C.J. Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey plasmacytoid dendritic cells. Clin. Diagn. Lab. Immunol. 12 (2005) 606-621
2. Alcon V., Baca-Estrada M., Vega-Lopez M., Willson P., Babiuk L.A., Kumar P., Hecker R., and Foldvari M. Mucosal delivery of bacterial antigens and CpG oligonucleotides formulated in biphasic lipid vesicles in pigs. Am. Assoc. Pharm. Sci. J. 7 (2005) E566-E571
3. Ashkar A.A., Bauer S., Mitchell W.J., Vieira J., and Rosenthal K.L. Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2. J. Virol. 77 (2003) 8948-8956
4. Ballas Z.K., Rasmussen W.L., and Krieg A.M. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157 (1996) 1840-1845
5. Booth J., Nichani A., Benjamin P., Dar A., Krieg A.M., Babiuk L.A., and Mutwiri G.K. Innate immune responses induced by classes of CpG oligodeoxynucleotides in ovine lymph nodes and blood mononuclear cells. Veterinary Immunol. Immunopathol. 115 (2007) 24-34
6. Deng J.C., Moore T.A., Newstead M.W., Zeng X., Krieg A.M., and Standiford T.J. CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection. J. Immunol. 173 (2004) 5148-5155
7. Elkins K.L., Rhinehart-Jones T.R., Stibitz S., Conover J.S., and Klinman D.M. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J. Immunol. 162 (1999) 2291-2298
8. Godson D.L., Campos M., Attah-Poku S.K., Redmond M.J., Cordeiro D.M., Sethi M.S., Harland R.J., and Babiuk L.A. Serum haptoglobin as an indicator of the acute phase response in bovine respiratory disease. Vet. Immunol. Immunopathol. 51 (1996) 277-292
9. Gomis S., Babiuk L., Godson D.L., Allan B., Thrush T., Townsend H., Willson P., Waters E., Hecker R., and Potter A. Protection of chickens against Escherichia coli infections by DNA containing CpG motifs. Infect. Immun. 71 (2003) 857-863
10. Gramzinski R.A., Doolan D.L., Sedegah M., Davis H.L., Krieg A.M., and Hoffman S.L. Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice. Infect. Immun. 69 (2001) 1643-1649
11. Harandi A.M., Eriksson K., and Holmgren J. A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection. J. Virol. 77 (2003) 953-962
12. Hartmann G., Battiany J., Poeck H., Wagner M., Kerkmann M., Lubenow N., Rothenfusser S., and Endres S. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. Eur. J. Immunol. 33 (2003) 1633-1641
13. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., and Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
14. Honda K., Ohba Y., Yanai H., Negishi H., Mizutani T., Takaoka A., Taya C., and Taniguchi T. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434 (2005) 1035-1040
15. Ioannou X.P., Gomis S.M., Karvonen B., Hecker R., Babiuk L.A., and van Drunen Littel-van den Hurk S. CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein. Vaccine 21 (2002) 127-137
16. Ioannou X.P., Griebel P., Hecker R., Babiuk L.A., and van Drunen Littel-van den Hurk S. The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides. J. Virol. 76 (2002) 9002-9010
17. Jacobs B.L., and Langland J.O. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 219 (1996) 339-349
18. Jurk M., Schulte B., Kritzler A., Noll B., Uhlmann E., Wader T., Schetter C., Krieg A.M., and Vollmer J. C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level. Immunobiology 209 (2004) 141-154
19. Klinman D.M. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat. Rev. Immunol. 4 (2004) 249-258
20. Klinman D.M. Use of CpG oligodeoxynucleotides as immunoprotective agents. Expert Opin. Biol. Ther. 4 (2004) 937-946
21. Klinman D.M., Yi A.K., Beaucage S.L., Conover J., and Krieg A.M. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 2879-2883
22. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20 (2002) 709-760
23. Krieg A.M., Efler S.M., Wittpoth M., Al Adhami M.J., and Davis H.L. Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist. J. Immunother. 27 (2004) 460-471
24. Krieg A.M., Love-Homan L., Yi A.K., and Harty J.T. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J. Immunol. 161 (1998) 2428-2434
25. Krieg A.M., and Wagner H. Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA. Immunol. Today 21 (2000) 521-526
26. Krug A., Rothenfusser S., Hornung V., Jahrsdorfer B., Blackwell S., Ballas Z.K., Endres S., Krieg A.M., and Hartmann G. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol. 31 (2001) 2154-2163
27. Latz E., Schoenemeyer A., Visintin A., Fitzgerald K.A., Monks B.G., Knetter C.F., Lien E., Nilsen N.J., Espevik T., and Golenbock D.T. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 5 (2004) 190-198
28. Marshall J.D., Fearon K., Abbate C., Subramanian S., Yee P., Gregorio J., Coffman R.L., and Van Nest G. Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions. J. Leukoc. Biol. 73 (2003) 781-792
29. Marshall J.D., Fearon K.L., Higgins D., Hessel E.M., Kanzler H., Abbate C., Yee P., Gregorio J., Cruz T.D., Lizcano J.O., Zolotorev A., McClure H.M., Brasky K.M., Murthy K.K., Coffman R.L., and Nest G.V. Superior activity of the type C class of ISS in vitro and in vivo across multiple species. DNA Cell Biol. 24 (2005) 63-72
30. Mason K.A., Ariga H., Neal R., Valdecanas D., Hunter N., Krieg A.M., Whisnant J.K., and Milas L. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy. Clin. Cancer Res. 11 (2005) 361-369
31. Mena A., Nichani A.K., Popowych Y., Godson D.L., Dent D., Townsend H.G., Mutwiri G.K., Hecker R., Babiuk L.A., and Griebel P. Innate immune responses induced by CpG oligodeoxyribonucleotide stimulation of ovine blood mononuclear cells. Immunology 110 (2003) 250-257
32. Mena A., Nichani A.K., Popowych Y., Ioannou X.P., Godson D.L., Mutwiri G.K., Hecker R., Babiuk L.A., and Griebel P. Bovine and ovine blood mononuclear leukocytes differ markedly in innate immune responses induced by class A and class B CpG-oligodeoxynucleotide. Oligonucleotides 13 (2003) 245-259
33. Mutwiri G., Nichani A.K., Babiuk S., and Babiuk L.A. Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides. J. Control Release 97 (2004) 1-17
34. Mutwiri G., Pontarollo R., Babiuk S., Griebel P., van Drunen Littel-van den Hurk S., Mena A., Tsang C., Alcon V., Nichani A., Ioannou X., Gomis S., Townsend H., Hecker R., Potter A., and Babiuk L.A. Biological activity of immunostimulatory CpG DNA motifs in domestic animals. Vet. Immunol. Immunopathol. 91 (2003) 89-103
35. Nichani A.K., Kaushik R.S., Mena A., Popowych Y., Dent D., Townsend H.G., Mutwiri G., Hecker R., Babiuk L.A., and Griebel P.J. CpG oligodeoxynucleotide induction of antiviral effector molecules in sheep. Cell Immunol. 227 (2004) 24-37
36. Nichani A.K., Mena A., Kaushik R.S., Mutwiri G.K., Townsend H.G., Hecker R., Krieg A.M., Babiuk L.A., and Griebel P.J. Stimulation of innate immune responses by CpG oligodeoxynucleotide in newborn lambs can reduce bovine herpesvirus-1 shedding. Oligonucleotides 16 (2006) 58-67
37. Nichani A.K., Mena A., Popowych Y., Dent D., Townsend H.G., Mutwiri G.K., Hecker R., Babiuk L.A., and Griebel P.J. In vivo immunostimulatory effects of CpG oligodeoxynucleotide in cattle and sheep. Vet. Immunol. Immunopathol. 98 (2004) 17-29
38. Nilsen T.W., Maroney P.A., and Baglioni C. Synthesis of (2′-5′)oligoadenylate and activation of an endoribonuclease in interferon-treated HeLa cells infected with reovirus. J. Virol. 42 (1982) 1039-1045
39. Pyles R.B., Higgins D., Chalk C., Zalar A., Eiden J., Brown C., Van Nest G., and Stanberry L.R. Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection. J. Virol. 76 (2002) 11387-11396
40. Rankin R., Pontarollo R., Ioannou X., Krieg A.M., Hecker R., Babiuk L.A., and van Drunen Littel-van den Hurk S. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev. 11 (2001) 333-340
41. Salmon P., Le Cotonnec J.Y., Galazka A., Abdul-Ahad A., and Darragh A. Pharmacokinetics and pharmacodynamics of recombinant human interferon-beta in healthy male volunteers. J. Interferon Cytokine Res. 16 (1996) 759-764
42. Sands H., Gorey-Feret L.J., Cocuzza A.J., Hobbs F.W., Chidester D., and Trainor G.L. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate. Mol. Pharmacol. 45 (1994) 932-943
43. Silverman R.H., Jung D.D., Nolan-Sorden N.L., Dieffenbach C.W., Kedar V.P., and SenGupta D.N. Purification and analysis of murine 2-5A-dependent RNase. J. Biol. Chem. 263 (1988) 7336-7341
44. Vollmer J., Weeratna R., Payette P., Jurk M., Schetter C., Laucht M., Wader T., Tluk S., Liu M., Davis H.L., and Krieg A.M. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur. J. Immunol. 34 (2004) 251-262
45. Wang Y., Abel K., Lantz K., Krieg A.M., McChesney M.B., and Miller C.J. The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques. J. Virol. 79 (2005) 14355-14370
46. Wong J.P., Nagata L.P., Christopher M.E., Salazar A.M., and Dale R.M. Prophylaxis of acute respiratory virus infections using nucleic acid-based drugs. Vaccine 23 (2005) 2266-2268
47. Zhao Q., Yu D., and Agrawal S. Site of chemical modifications in CpG containing phosphorothioate oligodeoxynucleotide modulates its immunostimulatory activity. Bioorg. Med. Chem. Lett. 9 (1999) 3453-3458